The Medical Journal of Australia · 2012 · 17 citations · 15 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsPharmacogenomicsGenetic DisordersGenetic SyndromesInherited Disease TestingMendelian DisordersRare Disease GeneticsSingle-gene DisordersAntihypertensive Drug TherapyAutosomal Dominant InheritanceGenetic Connective Tissue DisordersGenetic TestingMarfan Syndrome GeneticsMendelian Disorder GeneticsMolecular Genetic TestingSingle-gene Disorder Diagnosis
Marfan syndrome is a multisystem disorder of connective tissue that is inherited in an autosomal dominant fashion, and results from mutation of the FBN1 gene on human chromosome 15. There are a number of conditions of the connective tissue with a similar phenotype that can be confused with Marfan syndrome. Modifications of the diagnostic criteria have recently been published, facilitating the differentiation of Marfan syndrome from these conditions. It is still difficult to use modern genetic testing for diagnosis because Marfan syndrome can be caused by many different mutations in FBN1, a large gene with 65 coding segments, while mutations in other genes can cause overlapping phenotypes. Several clinical trials of drug therapy, including the antihypertensive drug losartan, are in progress.
15
The revised Ghent nosology for the Marfan syndrome: Table 1
Bart Loeys, Harry C. Dietz, Alan C. Braverman et al. · Journal of Medical Genetics · 2010 · 2.2K citations · Full text
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Jennifer Habashi, Daniel P. Judge, Tammy M. Holm et al. · Science · 2006 · 1.8K citations · Full text
Medicine, Cardiology, Pharmacology +15
Revised diagnostic criteria for the Marfan syndrome
Anne De Paepe, Richard B. Devereux, Harry C. Dietz et al. · American Journal of Medical Genetics · 1996 · 1.6K citations